40
Views
5
CrossRef citations to date
0
Altmetric
Original Research

A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy

, , &
Pages 3617-3623 | Published online: 20 Jul 2017

References

  • OshimiKProgress in understanding and managing natural killer-cell malignanciesBr J Haematol2007139453254417916099
  • SuzukiRTakeuchiKOhshimaKNakamuraSExtranodal NK/T-cell lymphoma: diagnosis and treatment cuesHematol Oncol2008262667218283711
  • SunJYangQLuZDistribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classificationAm J Clin Pathol2012138342943422912361
  • JainSZainJO’ConnorONovel therapeutic agents for cutaneous T-Cell lymphomaJ Hematol Oncol201217524
  • LimSTHeeSWQuekRComparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosisEur J Haematol2008801556018028433
  • LinJCWangWYChenKYQuantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinomaN Engl J Med2004350242461247015190138
  • HohausSSantangeloRGiachellaMThe viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphomaClin Cancer Res20111792885289221478335
  • LiYXYaoBJinJRadiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphomaJ Clin Oncol20062491181189
  • IsobeKUnoTTamaruJExtranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parametersCancer2006106360961516369986
  • RibragVEll HajjMJanotFEarly locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynxLeukemia20011571123112611455983
  • Sobrevilla-CalvoPMenesesAAlfaroPBaresJPAmadorJReynosoEERadiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis)Acta Oncol199332169728466767
  • KimSJKimKKimBSPhase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: consortium for improving survival of lymphoma studyJ Clin Oncol200927356027603219884539
  • YamaguchiMTobinaiKOguchiMConcurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211J Clin Oncol201230324044404623045573
  • LeeHJLeeSWSuhCTreatment outcome of nasal natural killer/T-cell lymphomaRadiat Oncol J201129317418022984668
  • LeeJKimCYParkYJLeeNKSequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal typeBlood Res201348427428124466552
  • YangYZhangYJSunYPreliminary outcome of concurrent chemoradiation therapy in patients with early stage extranodal nasal type NK/T-cell lymphomaChin J Cancer Prev Treat2012196378381
  • YouJYChiKHYangMHRadiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in TaiwanAnn Oncol200415461862515033670
  • HuangMJJiangYLiuWPEarly or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tractInt J Radiat Oncol Biol Phys200870116617417919841
  • CoxJDStetzJPajakTFToxicity of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)Int J Radiat Oncol Biol Phys1995315134113467713792
  • ShenQMaXHuWIntensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I/II natural killer T-cell lymphoma nasal type: dosimetric and clinical resultsRadiat Oncol2013815223800149